Navigation Links
Study Finds Ponseti Method of Clubfoot Correction Leads to Lower Surgical Rates and Less Revision Surgery

Less serious recurrence seen with Ponseti casting method

ROSEMONT, Ill., Feb. 1 /PRNewswire-USNewswire/ -- Clubfoot affects one in a thousand babies born in the United States, but with proper corrective treatment and follow-up, infants born with clubfoot can have feet compatible with an active, normal lifestyle. A new study in the February 2010 issue of The Journal of Bone and Joint Surgery (JBJS) compared two common treatment options for clubfoot – Ponseti method and surgical treatment.  

"While more conservative treatment methods have become popular in the United States over the last several years, surgical treatment has been the primary option in New Zealand until quite recently," explained Matthew Halanski, MD, who authored the study with mentors at the Starship Children's Hospital in Auckland, New Zealand.

"This is the first controlled prospective study to compare the short-term outcomes for clubfeet treated either surgically or with the Ponseti method," continued Dr. Halanski.

Fifty-five patients with 86 clubfeet were treated as part of the study.  Forty patients' feet were treated with the Ponseti method.  Forty-six were treated with surgery and casting. The average number of casts per patient was six in the Ponseti Group and 13 in the surgical group.

The study found that among the patients treated:

  • Fifteen feet in the Ponseti group had a recurrence requiring some surgery. Four of these feet had a major recurrence and 11 had a minor recurrence.
  • Fourteen feet in the surgical group required revision (follow-up) surgery.  
  • Only one foot in the Ponseti group required revision surgery.

Patients treated in both groups had a 30 percent to 40 percent rate of relapse. While this is a relatively high recurrence rate for both groups, feet in the Ponseti group needed significantly less invasive operative intervention and required less revision surgery.  And for patients in the surgical group who required revision surgery, it was actually a repeat procedure, which has been shown in other studies to lead to poorer function.

"The case for Ponseti treatment is much stronger than for surgery considering Ponseti treatment involves less severe recurrence; and feet treated with too many surgeries have less favorable outcomes," said Dr. Halanski, who is now a practicing pediatric orthopaedic surgeon at the Helen DeVos Children's Hospital in Grand Rapids, Michigan and also clinical assistant professor in the Department of Surgery and Pediatrics & Human Development, Michigan State University College of Human Medicine.

The Ponseti method has been adopted as the primary treatment for clubfoot at the children's hospital in New Zealand where the study took place.

"Any infant born with clubfoot should be taken to an orthopaedic surgeon specializing in pediatrics, preferably within the first few months of life," concluded Dr. Halanski.  "While primary surgical treatment may still be required in select cases, we strongly advise any parent who receives a recommendation for surgery as primary treatment to seek a second opinion."

About Clubfoot

Clubfoot is a complex deformity in which the feet are twisted inward with the top of the foot where the bottom should be. This condition can sometimes be detected in a prenatal ultrasound, but always is readily apparent at birth. Despite successful initial treatment, clubfeet have a natural tendency to recur. Regardless of medical treatment option, bracing is necessary for several years post treatment to prevent relapses, almost constantly for a few months, then typically during sleep.

The study took place in New Zealand where clubfoot is more common due to the heavy Polynesian population and the propensity for clubfoot among Polynesians. This study reviewed the two most common treatments of clubfoot:

  • Ponseti method involves weekly manipulation with above-knee casting often followed by cutting of the Achilles tendon to correct the condition; bracing is then used to maintain the correction.
  • Surgical correction involves lengthening of the Achilles tendon and release of the ankle joint, multiple joints in the foot, often with re-alignment and pinning of the bones in the foot.

More information on clubfoot symptoms and treatment can be found on

About Ponseti: Ignacio V. Ponseti, MD was still treating patients and practicing medicine at the age of 95 when he passed away in 2009. Although best-known for his pioneering treatment of clubfoot, Dr. Ponseti made other significant contributions to orthopaedic surgery. From 1942 to 2009, he published more than 120 scientific papers on clubfoot and conditions such as developmental hip dysplasia, Perthes disease, skeletal dysplasia, and scoliosis. A cofounder of the Orthopaedic Research Society, Dr. Ponseti also was an advisor to the National Institutes of Health and an editorial board member for leading orthopaedic journals. Many orthopaedic surgeons identify him as a friend, mentor and teacher who was admired for his compassion and dedication.

Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity.

For further information:


SOURCE American Academy of Orthopaedic Surgeons



SOURCE American Academy of Orthopaedic Surgeons
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Halt Uterine Fibroid Study Attracts National Media Attention
2. Nationwide Study Finds That Teenage Girls Have Mixed Feelings About the Fashion Industry
3. Study suggests that healthy adults may need less sleep as they age
4. Study finds reduced brain gray matter concentration in patients with severe obstructive sleep apnea
5. Study Shows Cigarette Smoking a Risk Factor for Alzheimer's Disease
6. Fat Tissue May Be a Source of Valuable Blood Stem Cells, Study Says
7. More Recruiting of Underrepresented Minorities Needed at U.S. Medical Schools, Study Says
8. Researchers find new way to study how enzymes repair DNA damage
9. Study says lead may be the culprit in ADHD
10. Study examines sexual orientation and bullying among adolescents
11. Fat tissue may be a source of valuable blood stem cells, study says
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can ... "I conceived of this design due to personal experience with a bad back," he ... relaxation and convenience, as well as increases support. It also makes it easier to ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... carried out by the University of Toronto and the University of British Columbia suggested ... hospitalizations for head injuries. The article explains that part of the reason for the ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: